His scientific interests lie mostly in Internal medicine, Endocrinology, Fibroblast, Immunology and Receptor. As a member of one scientific family, Terry J. Smith mostly works in the field of Internal medicine, focusing on Monoclonal and, on occasion, Teprotumumab. The study incorporates disciplines such as T cell, Glycosaminoglycan and Insulin-like growth factor in addition to Endocrinology.
His research integrates issues of Cytokine, Inflammation, Connective tissue, Pathology and Cell biology in his study of Fibroblast. His Immunology research incorporates elements of Graves' ophthalmopathy and Disease. His Receptor study deals with Cancer research intersecting with Chemokine.
His primary scientific interests are in Internal medicine, Endocrinology, Molecular biology, Graves' disease and Immunology. His work in Internal medicine addresses issues such as T cell, which are connected to fields such as Lymphocyte. His studies deal with areas such as Receptor, Cytokine, Connective tissue and Fibroblast as well as Endocrinology.
Terry J. Smith interconnects Inflammation, Prostaglandin E2, Glycosaminoglycan and Cell biology in the investigation of issues within Fibroblast. His Molecular biology research includes elements of Genetics, Complementary DNA, Messenger RNA, Gene and Exon. Terry J. Smith regularly links together related areas like Antigen in his Graves' disease studies.
Terry J. Smith spends much of his time researching Graves' disease, Internal medicine, Immunology, Receptor and Endocrinology. His Graves' disease research is multidisciplinary, incorporating elements of Antigen, Monoclonal antibody and Pathogenesis. His Pathogenesis study incorporates themes from Thyrotropin receptor and Insulin-like growth factor.
His Internal medicine study typically links adjacent topics like Gene expression. His Receptor research is multidisciplinary, incorporating perspectives in Cancer research, Proinflammatory cytokine, Fibroblast, Autoimmunity and Western blot. As a part of the same scientific study, Terry J. Smith usually deals with the Endocrinology, concentrating on Signal transduction and frequently concerns with Cytokine.
Terry J. Smith mostly deals with Immunology, Graves' disease, Internal medicine, Neuromyelitis optica and Thyroid. Terry J. Smith has included themes like Graves' ophthalmopathy and Signal transduction in his Immunology study. His Graves' disease research is multidisciplinary, relying on both Surgery, Receptor, Interleukin, CTLA-4 and FOXP3.
He usually deals with Receptor and limits it to topics linked to Antigen and Growth factor and Insulin-Like Growth Factor Receptor. The Internal medicine study combines topics in areas such as Endocrinology and Oncology. His studies in Endocrinology integrate themes in fields like Ex vivo and Cellular differentiation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.
R. S. Smith;T. J. Smith;T. M. Blieden;R. P. Phipps.
American Journal of Pathology (1997)
Current Perspective on the Pathogenesis of Graves’ Disease and Ophthalmopathy
Bellur S. Prabhakar;Rebecca S. Bahn;Terry J. Smith;Terry J. Smith.
Endocrine Reviews (2003)
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.
Melvin B. Heyman;Barbara S. Kirschner;Benjamin D. Gold;George Ferry.
The Journal of Pediatrics (2005)
An update of recent evidence of the relationship between objective and self-report measures of the physical environment and physical activity behaviours
Gavin Mccormack;Billie Giles-Corti;Andrea Lange;T. Smith.
Journal of Science and Medicine in Sport (2004)
Connective tissue, glycosaminoglycans, and diseases of the thyroid.
Terry J. Smith;Rebecca S. Bahn;Colum A. Gorman.
Endocrine Reviews (1989)
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J. Smith;George J. Kahaly;Daniel G. Ezra;James C. Fleming.
The New England Journal of Medicine (2017)
Thy-1 Expression in Human Fibroblast Subsets Defines Myofibroblastic or Lipofibroblastic Phenotypes
Laura Koumas;Terry J. Smith;Steven Feldon;Neil Blumberg.
American Journal of Pathology (2003)
Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway.
Jane Pritchard;Rui Han;Noah Horst;William W. Cruikshank.
Journal of Immunology (2003)
Relationship Between Reported and Measured Sleep Times: The Sleep Heart Health Study (SHHS)
Graciela E. Silva;James L. Goodwin;Duane L. Sherrill;Jean L. Arnold.
Journal of Clinical Sleep Medicine (2007)
Evidence for an Association between Thyroid-Stimulating Hormone and Insulin-Like Growth Factor 1 Receptors: A Tale of Two Antigens Implicated in Graves’ Disease
Shanli Tsui;Vibha Naik;Neil Hoa;Catherine J. Hwang.
Journal of Immunology (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: